← Eichor
Condition: Nasopharyngeal Carcinoma Npc Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Nasopharyngeal Carcinoma Npc

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Nedaplatin Versus Cisplatin in Treatment for Nasopharyngeal Carcinoma
Phase 3 · 1 location(s) · Affiliated Cancer Hospital & Institute of Guangzhou Medical · NCT04437329Adjuvant vs Surgery Only in Early-stage Recurrent NPC
Phase 3 · 7 location(s) · Eye & ENT Hospital of Fudan University · NCT06228079Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patient
Phase 2 · 153 location(s) · NRG Oncology · NCT06532279Effect of Immunonutrients on Oral Mucositis in Nasopharyngeal Carcinoma Patients After Chemoradiotherapy
NA · 20 location(s) · First Affiliated Hospital of Guangxi Medical University · NCT05892354An International Study on Pediatric Patients With Rare Tumors.
Phase N/A · 1 location(s) · Azienda Ospedaliera di Padova · NCT07072143Clinical Study on the EBV CAR-T /TCR-T Cells in the Treatment of Nasopharyngeal Carcinoma
EARLY_Phase 1 · 1 location(s) · Fudan University · NCT05587543RAIRI Model-Guided Adjuvant Therapy in Nasopharyngeal Carcinoma
Phase 3 · 1 location(s) · Cancer Institute and Hospital, Chinese Academy of Medical Sc · NCT07590024De-escalated Radiotherapy for Primary Tumor After Neoadjuvant Therapy With Toripalimab Plus Chemotherapy for Nasopharyng
NA · 1 location(s) · Sun Yat-sen University · NCT06313450GP Plus Adebrelimab Versus GP Neoadjuvant Chemotherapy for Nasopharyngeal Carcinoma
Phase 2 · 12 location(s) · Sun Yat-sen University · NCT06455410Reduced-dose vs Standard-dose Irradiation for Low-risk Clinical Target Volume in Nasopharyngeal Carcinoma.
Phase 3 · 6 location(s) · Sun Yat-sen University · NCT07201337LDRT Combined With Toripalimab and Chemotherapy for Recurrent/Metastatic NPC
Phase 2 · 2 location(s) · Sun Yat-sen University · NCT07325539Metastatic Nasopharyngeal Carcinoma
Phase 1 · 1 location(s) · Chen Xiaozhong · NCT06886347Proton Therapy for Recurrent Nasopharyngeal Carcinoma
NA · 2 location(s) · Guangzhou Concord Cancer Center · NCT07412314Gemcitabine Combined With Endostar and Envafolimab in Elderly Patients With Locally Advanced Nasopharyngeal Carcinoma
Phase 2 · 1 location(s) · Zhejiang Cancer Hospital · NCT06055816Real-World RAIRI-Guided Risk Stratification for Adjuvant Therapy Benefit After Chemoradiotherapy in NPC
Phase N/A · 1 location(s) · Cancer Institute and Hospital, Chinese Academy of Medical Sc · NCT07618078tReatment Individualisation By EBV stratificatiON in Nasopharyngeal Carcinoma: an Umbrella Platform Study (RIBBON-Umbrel
Phase N/A · 1 location(s) · National Cancer Centre, Singapore · NCT05517135Anti-PD1 Monoclonal Antibody Combined With Nimotuzumab and Capecitabine in Patients With First-line Platinum-resistant R
Phase 2 · 1 location(s) · Jiangxi Provincial Cancer Hospital · NCT06259721Pretreatment With HCQ Before Radiotherapy and Chemotherapy in Advanced NPC Patients
NA · 1 location(s) · Affiliated Hospital of Nantong University · NCT06389201A Randomized Controlled Trial of Spermidine for the Prevention of Radiation-Induced Xerostomia in Head and Neck Squamous
Phase 1/Phase 2 · 1 location(s) · West China Hospital · NCT0703562618F-FDG PET/CT Guided Reduced-dose Radiotherapy for Nasopharyngeal Carcinoma
Phase 2 · 4 location(s) · Taizhou Hospital · NCT04813705To Develop and Validate a Nasoendoscopic Intelligent Diagnostic System for Nasopharyngeal Carcinoma
Phase N/A · 3 location(s) · First Affiliated Hospital, Sun Yat-Sen University · NCT04547673Individualized Neck Cervical Irradiation Prophylaxis Trial of NPC
Phase 3 · 6 location(s) · Fudan University · NCT07303023Effect of Standard Nutrition Therapy on Nutritional Status and Prognosis in Locoregionally Advanced Nasopharyngeal Carci
Phase 3 · 1 location(s) · Sun Yat-sen University · NCT04436965Envafolimab Combined With Chemoradiotherapy and Recombinant Human Endostatin for LA-NPC.
Phase 2 · 1 location(s) · Chongqing University Cancer Hospital · NCT06059261CTV Delineation Based Solely on Geometric Expansion From GTV in Nasopharyngeal Carcinoma
Phase 3 · 1 location(s) · Fujian Cancer Hospital · NCT06095154Nab-TPC vs GP Combined With Camrelizumab in the Treatment of Recurrent/Metastatic Nasopharyngeal Carcinoma
Phase 3 · 1 location(s) · Sun Yat-sen University · NCT06669611A Phase Ib/II Study of an Anti-HER3 Antibody, HMBD-001, With Cetuximab +/- Docetaxel in Advanced Squamous Cell Cancers
Phase 1/Phase 2 · 20 location(s) · Hummingbird Bioscience · NCT05910827A Phase III Study of YL201 in Recurrent or Metastatic Nasopharyngeal Carcinoma
Phase 3 · 1 location(s) · MediLink Therapeutics (Suzhou) Co., Ltd. · NCT06629597Combination Therapy for PD-1 Resistant Recurrent or Metastatic Nasopharyngeal Carcinoma: A Bayesian Adaptive Phase II Tr
Phase 2 · 6 location(s) · Ming-Yuan Chen · NCT07070479A Mucosal Contouring Method Based on Swallowing-induced Breakthrough Pain for Radiation-induced Oropharyngeal Mucositis
Phase N/A · 1 location(s) · Nanfang Hospital, Southern Medical University · NCT06287788
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.